Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Pfizer shares have gained ground since a report over the weekend said that activist investor ...

AbbVie focuses on specialized therapies in immunology, oncology, and neuroscience. The company sells these treatments globally, relying heavily on three major wholesale distributors: McKesson ...

I last covered Pfizer Inc. stock (PFE) on Nov 8, 2025, with an article titled "Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer". The article mainly served as a review for the company's FQ3 ...

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.

*Pfizer updated its commercial structure in Q1 2026 by moving certain off-patent branded products, generic sterile injectables, and biosimilars from its Specialty Care and Oncology portfolios into a ...

Pharmaceutical stocks are drawing renewed attention as investors look for areas of the market that can hold up in a more uncertain environment. As volatility increases and growth expectations become ...

Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value has taken a roughly $1 billion stake in the drug maker and is pushing for changes. The ...